March 14, 2026

Stock Brokers

Stock Brokers

Brokers Set Expectations for DDI Q1 Earnings

DoubleDown Interactive Co., Ltd. (NASDAQ:DDI – Free Report) – Analysts at B. Riley issued their Q1 2025 EPS estimates for DoubleDown Interactive in a research report issued to clients and investors on Monday, February 24th. B. Riley analyst J. Nichols forecasts that the company will post earnings per share of $0.53 for the quarter. B.

Read More
Stock Brokers

Stock market correction could slash brokerage earnings

Indian stock markets are undergoing a significant correction, leading to a sharp decline in trading volumes across brokerage platforms. With indices sliding and investor sentiment turning bearish, brokerage firms are witnessing their first major slowdown in over a decade, which is likely to hit their revenues, according to industry experts. Nithin Kamath, Chief Executive Officer

Read More
Stock Brokers

Trading volumes down 30% across stock brokers: Zerodha’s Nithin Kamath

Trading volumes have plummeted by 30% across stock brokers, marking the first instance of degrowth for Zerodha since its inception, Nithin Kamath, its chief executive officer, said in a post on the social media platform ‘X’ (previously Twitter). — Nithin0dha (@Nithin0dha) While he did not disclose specific impacts on Zerodha, Kamath highlighted broader industry trends.

Read More
Stock Brokers

Brokers Issue Forecasts for TBPH FY2024 Earnings

Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) – Equities research analysts at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for Theravance Biopharma in a note issued to investors on Tuesday, February 25th. HC Wainwright analyst D. Tsao forecasts that the biopharmaceutical company will post earnings per share of ($1.01) for the year.

Read More
Stock Brokers

Brokers name 2 ASX dividend stocks to buy now

Image source: Getty Images There are a lot of ASX dividend stocks to choose from on the local share market. But which ones could be in the buy zone right now? Let’s take a look at two that brokers are tipping as buys. Here’s what they are saying about them: NIB Holdings Limited (ASX: NHF)

Read More
Stock Brokers

What are the perils of using ‘buy now, pay later’ option for stock purchases

To be sure, most brokers in India offer a margin trading facility (MTF), positioning it as a “buy now, pay later” option. In this option, investors can use brokers’ funds to buy more stocks if they don’t have adequate capital. Zerodha, the country’s largest broker in terms of active clients, was among the latest brokers

Read More
Stock Brokers

AVGMETA vs. Traditional Brokers: The Advantages of Decentralized Stock Trading

Share Tweet Share Share Email The financial landscape is evolving rapidly, and decentralized stock trading is emerging as a game-changer for investors worldwide. Avgmeta is at the forefront of this revolution, offering a modern alternative to traditional brokerage systems. Unlike conventional brokers, which often impose geographic and regulatory

Read More
Stock Brokers

SEBI slaps ₹10 lakh penalty on Axis Securities for violating stock brokers rules

Capital markets regulator SEBI has imposed a penalty of ₹10 lakh on Axis Securities for flouting stock brokers rules as well as other regulatory norms. Company Value Change %Change The penalty has to be paid by the brokerage firm within 45 days, the regulator said in an order on Friday (February 21). In an 82-page

Read More
Stock Brokers

Sebi slaps Rs 10 lakh penalty on Axis Securities for violating stock brokers rules

Capital markets regulator Sebi has imposed a penalty of Rs 10 lakh on Axis Securities for flouting stock brokers rules as well as other regulatory norms. The penalty has to be paid by the brokerage firm within 45 days, the regulator said in an order on Friday. In an 82-page order, Sebi found that Axis

Read More
Stock Brokers

Brokers Offer Predictions for VRTX FY2025 Earnings

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Vertex Pharmaceuticals in a research note issued to investors on Wednesday, February 19th. Cantor Fitzgerald analyst O. Brayer expects that the pharmaceutical company will post earnings per share of $16.12 for the year. Cantor Fitzgerald currently has

Read More